Loading…
FibroBiologics, Inc. is projected to rise to $1.22 by 2027, a +33% move from its current price of $0.9167. FBLG is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $0.8714 | $0.9173 | $0.9657 | +0.07% |
| Jul 13 | $0.8536 | $0.918 | $0.9872 | +0.14% |
| Jul 14 | $0.8404 | $0.9186 | $1.00 | +0.21% |
| Jul 15 | $0.8294 | $0.9193 | $1.02 | +0.28% |
| Jul 16 | $0.82 | $0.9199 | $1.03 | +0.35% |
| Jul 17 | $0.8116 | $0.9206 | $1.04 | +0.42% |
| Jul 18 | $0.804 | $0.9212 | $1.06 | +0.49% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.804 | $0.9212 | $1.06 | +0.49% |
| Week 2 | $0.7637 | $0.9257 | $1.12 | +0.98% |
| Week 3 | $0.735 | $0.9302 | $1.18 | +1.48% |
| Week 4 | $0.7122 | $0.9348 | $1.23 | +1.98% |
| Week 5 | $0.693 | $0.9394 | $1.27 | +2.48% |
| Week 6 | $0.6765 | $0.944 | $1.32 | +2.98% |
| Week 7 | $0.6619 | $0.9486 | $1.36 | +3.48% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
FibroBiologics, Inc. is a clinical-stage biotechnology company focused on the development and commercialization of fibroblast-based therapies for patients suffering from chronic diseases. The company's product pipeline includes CYWC628 which has completed pre-clinical trial for the treatment of wound healing; CYMS101 which has completed Phase 1 trial for the treatment of multiple sclerosis; CybroCell for the treatment of degenerative disc disease; and CYPS317 for the treatment of psoriasis.
It also develops early-stage research products, including CYTER915 to treat the human longevity; and TCB190 for the treatment of certain cancers. FibroBiologics, Inc. was incorporated in 2021 and is headquartered in Houston, Texas.
FibroBiologics, Inc. trades under the symbol FBLG. It currently trades at $0.9167 per share with a market capitalization of $4.78M and holds the 5285th rank by market cap. The current price sits near the initial forecast, with a long-run outlook showing gradual upside potential.
The 2026 forecast shows a neutral stance with a min price of $0.733, an avg price of $0.9167 and a max price of $1.45, while longer horizon years illuminate bullish potential in the 2032–2050 window, including a 2040 avg of $1.88 and a 2050 avg of $2.63.
A major floor 44.4% below — a decisive break under it would weaken the trend.
The nearest floor, 20.0% below — buyers have tended to step in here.
The nearest ceiling, 26.5% above — a clean break opens room to run.
A major ceiling 849.1% above — clearing it would confirm fresh momentum.
Key FBLG support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of FBLG market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.8608 | Buy | $0.8725 | Buy |
| MA 10 | $0.8655 | Buy | $0.8628 | Buy |
| MA 20 | $0.844 | Buy | $0.8849 | Buy |
| MA 50 | $1.01 | Sell | $1.27 | Sell |
| MA 100 | $2.57 | Sell | $2.46 | Sell |
| MA 200 | $4.80 | Sell | $7.68 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 48.78 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 85.54 | Neutral |
| Williams %R (14) | -14.42 | Info |
| MACD (12,26,9) | 0.03 | Buy |
| ROC (12) | 22.27 | Buy |
| Bollinger %B (20,2) | 0.78 | Neutral |
| Stochastic %K (14) | 85.58 | Sell |
| TRIX (15) | -1.12 | Sell |
| Awesome (5,34) | -0.07 | Sell |
| Ultimate (7,14,28) | 47.87 | Neutral |
| Momentum (10) | 0.18 | Buy |
| Aroon Osc (25) | -56.00 | Sell |
| Hull MA (9) | 0.85 | Buy |
| ADX (14) | 28.26 | Sell |
| ATR (14) | 0.05 | Info |
The near-term technical picture remains neutral. The RSI (14) sits at 50, and the sentiment is NEUTRAL. The stock is trading around its 50-day simple moving average of $1.01, well below its 200-day simple moving average of $4.80, signaling a depress but consolidating price action.
Support is at $0.733 and resistance at $1.16, with a 30-day price range between $0.6532 and $1.29. These levels provide a framework for potential bounce or pullback in the coming weeks.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.733 | $0.9167 | $1.45 | 0% | Neutral | |
| $0.8902 | $1.22 | $1.80 | +33% | Bullish | |
| $0.7374 | $1.07 | $1.68 | +17% | Neutral | |
| $0.6911 | $1.05 | $1.74 | +15% | Neutral | |
| $0.6355 | $1.01 | $1.74 | +10% | Neutral | |
| $0.5439 | $0.9039 | $1.60 | -1% | Neutral | |
| $0.7149 | $1.24 | $2.26 | +35% | Bullish | |
| $0.7822 | $1.41 | $2.64 | +53% | Bullish | |
| $0.7485 | $1.40 | $2.68 | +52% | Bullish | |
| $0.7539 | $1.46 | $2.87 | +59% | Bullish | |
| $0.8463 | $1.88 | $4.06 | +105% | Bullish | |
| $1.18 | $2.63 | $6.05 | +187% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $0.733 | $0.9167 | $1.13 | +0.00% |
| August 2026 | $0.8111 | $0.9809 | $1.23 | +7.01% |
| September 2026 | $0.797 | $0.977 | $1.25 | -0.40% |
| October 2026 | $0.769 | $0.9537 | $1.25 | -2.38% |
| November 2026 | $0.8129 | $1.02 | $1.35 | +6.76% |
| December 2026 | $0.8535 | $1.08 | $1.45 | +5.98% |
Click any year to see its month-by-month FBLG forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, FBLG is projected to trade between $0.733 and $1.45, averaging $0.9167 — a potential gain of 0% from today's $0.9167. Price action looks broadly range-bound.
FibroBiologics, Inc.'s 2027 outlook centres on $1.22, within a $0.8902 to $1.80 range. That is up +33% on the projected 2026 average. That marks a +33% change versus current levels. Buyers look set to stay in control over this stretch.
By 2028, FBLG could reach as high as $1.68, with a base case around $1.07 and support toward $0.7374 — roughly +17% from $0.9167. Price action looks broadly range-bound.
Expect FBLG to range from $0.6911 to $1.74 through 2029. The $1.05 average target implies a +15% move from current prices. That is -2% versus the projected 2028 average. A consolidation phase looks the most probable path here.
The FBLG price prediction for 2030 points to an average of $1.01 (low $0.6355, high $1.74) — a potential gain of +10% on today's $0.9167. Price action looks broadly range-bound.
In 2031, FBLG is projected to trade between $0.5439 and $1.60, averaging $0.9039 — a potential decline of -1% from today's $0.9167. That is -11% versus the projected 2030 average. A consolidation phase looks the most probable path here.
FibroBiologics, Inc.'s 2032 outlook centres on $1.24, within a $0.7149 to $2.26 range. That is up +37% on the projected 2031 average. That marks a +35% change versus current levels. Momentum favours further upside here.
By 2033, FBLG could reach as high as $2.64, with a base case around $1.41 and support toward $0.7822 — roughly +53% from $0.9167. Buyers look set to stay in control over this stretch.
Expect FBLG to range from $0.7485 to $2.68 through 2034. The $1.40 average target implies a +52% move from current prices. That is -1% versus the projected 2033 average. Momentum favours further upside here.
The FBLG price prediction for 2035 points to an average of $1.46 (low $0.7539, high $2.87) — a potential gain of +59% on today's $0.9167. Buyers look set to stay in control over this stretch.
In 2040, FBLG is projected to trade between $0.8463 and $4.06, averaging $1.88 — a potential gain of +105% from today's $0.9167. That is up +29% on the projected 2035 average. Momentum favours further upside here.
FibroBiologics, Inc.'s 2050 outlook centres on $2.63, within a $1.18 to $6.05 range. That is up +40% on the projected 2040 average. That marks a +187% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in FBLG today (≈ 1,090.869423 FBLG) could be worth
$2,868.92
+$1,868.92 (+187%) by 2050 · US Dollar
Based on the average projected FBLG price of $2.63 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in FBLGwould be worth at today's price.
$1,000 invested in FBLG on Jul 10, 2025 (≈ 77.041605 FBLG) would be worth
$70.62
-$929.38 (-92.9%) today · 0.07× · US Dollar
Based on a FBLG entry price of $12.98 vs. today's $0.9167.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.876 | $1,046.46 | +4.6% |
| 1 month ago | $0.954 | $960.9 | -3.9% |
| 3 months ago | $1.35 | $679.04 | -32.1% |
| 6 months ago | $7.7 | $119.05 | -88.1% |
| 1 year ago | $12.98 | $70.62 | -92.9% |
| All time (2.4y) ago | $582 | $1.58 | -99.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our FBLG forecast.
Our base-case forecast reaches $1.80 around 2040.
Implied market cap at $1.80: $9.38M
Looking further out, the multi-year forecast shows continued upside potential with a generally bullish tilt in the later years. The 2027 forecast is avg $1.22, with a max of $1.80 and a min $0.8902, and a 32.9% ROI, signaling stronger momentum. By 2032 the forecast turns more buoyant, with avg $1.24 and a max $2.26, ROI 34.9, indicating rising investor optimism.
The 2033–2035 window strengthens, with 2033 avg $1.41 (ROI 53.3, max $2.64), 2034 avg $1.40 (ROI 52.3, max $2.68), and 2035 avg $1.46 (ROI 59, max $2.87). The long-horizon outlook shows substantial upside: 2040 avg $1.88 (ROI 105.2, max $4.06) and 2050 avg $2.63 (ROI 186.9, max $6.05), with bullish sentiment in these years. While these are estimates, they illustrate potential upside but are not guarantees, and risk factors can influence outcomes.
Tap a question to reveal the answer.
2030 forecast: min $0.6355, avg $1.01, max $1.74; ROI 10.5%; sentiment NEUTRAL.
The long-run outlook shows upsides with years like 2027 (avg $1.22, ROI 32.9) and 2040 (avg $1.88, ROI 105.2), but these figures are estimates and not guarantees; current price may vary and risks exist.
Yes. The forecast shows a max of $2.64 in 2033 and $2.68 in 2034 and $2.87 in 2035, indicating prices above $2 in several years.
The near-term indicators show sentiment NEUTRAL; RSI(14) is 50; SMA50 is $1.01; SMA200 is $4.80; support at $0.733 and resistance at $1.16; 30-day range from $0.6532 to $1.29.
Current price is $0.9167. Market cap is $4.78M and the rank is 5285.
FibroBiologics, Inc. Community Discussion
0Share your FibroBiologics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.